Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

King Fluogen Discontinued; Flu Vaccine Would Have Been Unavailable In 2000

Executive Summary

King Pharmaceuticals will discontinue Fluogen following receipt of a Sept. 27 FDA letter concerning the flu vaccine.

You may also be interested in...



Aventis To Increase Fluzone Supply As Wyeth’s FluShield Exits Market

Aventis-Pasteur is in discussions with FDA and the Centers for Disease Control & Prevention on ways to increase the supply of its influenza vaccine Fluzone following Wyeth's decision to discontinue FluShield

Aventis To Increase Fluzone Supply As Wyeth’s FluShield Exits Market

Aventis-Pasteur is in discussions with FDA and the Centers for Disease Control & Prevention on ways to increase the supply of its influenza vaccine Fluzone following Wyeth's decision to discontinue FluShield

Vaccine Stockpile Strategy Cost Implications Should Be Considered – NVAC

The cost implications for vaccine storage strategies need to be considered in developing a national stockpile, National Immunization Program Director Walter Orenstein, MD, told a National Vaccine Advisory Committee workgroup April 1

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel